Canagliflozin
Canagliflozin (Invokana) is an SGLT2 inhibitor used for type 2 diabetes. This listing contains the Invokana tablet, linking the ingredient with diabetes management.
Key points
- Glucose excretion: Canagliflozin reduces glucose reabsorption in the kidneys, so more glucose leaves the body in urine.
- Medicine-specific safety: Ketoacidosis, dehydration, genital infections and foot complications are important safety topics for this medicine.
What Canagliflozin is used for
Canagliflozin is listed here through Invokana, a single-ingredient 100mg tablet in Diabetes Management. It is used for Type 2 Diabetes Mellitus, where controlling blood glucose is a treatment goal.
